-
After the flood, pay attention to scientific epidemic prevention
Time of Update: 2021-07-30
After the flood disaster, what issues should the public pay attention to in terms of hygiene and epidemic prevention?
-
Why has the number of cases increased significantly in the past two days?
Time of Update: 2021-07-30
Ding Jie, deputy director of the Nanjing Centers for Disease Control and Prevention, said that the recent increase in case reports is mainly due to the particularity of the place where the epidemic occurred and the strong contagion of the virus .
-
my country's inhaled new crown vaccine clinical trial results are recognized by authorities
Time of Update: 2021-07-30
At the same time, aerosol inhalation can also significantly improve the multiple immune effects of people who have been injected with the vaccine, resist the mutation of the new coronavirus, and is suitable for large-scale population promotion .
-
The State Food and Drug Administration issued a notice on timely submission of the original and auxiliary package annual report
Time of Update: 2021-07-30
The relevant content of the annual report system for the original and auxiliary package is summarized as follows:(1) On November 23, 2017, the State Administration issued the "Announcement on Adjusting the Review and Approval of APIs, Pharmaceutical Excipients and Pharmaceutical Packaging Materials (2017 No.
-
Singaporean scholars: oppose the politicization of the origin of the new crown virus
Time of Update: 2021-07-30
Ma Kai Singapore's former Permanent Representative of the United Nations, excellent Asian Institute, National University of Singapore Academy of Sciences Ma Shuo said that since the new crown outbreak, the United States and other Western countries continue to be stigmatized virus traceability issues, politicized .
-
Notice on matters related to the registration of drug-device combination products
Time of Update: 2021-07-30
If joint review is required, the registration application materials shall be forwarded to the Medical Device Technology Review Center for simultaneous review; the drug-device combination products declared in accordance with the medical device registration shall be reviewed.
-
The German Medical Data Project welcomes its 36th member
Time of Update: 2021-07-30
Image source: Dresden-Rosendorf Helmholtz Research CenterThe Dresden-Rosendorf Helmholtz Research Center, Germany, will be responsible for running the PIONEER project's big data platform for prostate cancer .
In addition to providing cloud infrastructure for the PIONEER big data platform, CASUS will also provide joint data analysis for all members of the project .
-
The first class 1 new drug!
Time of Update: 2021-07-30
On July 24, the CDE official website showed that Qilu Pharmaceutical submitted and accepted a listing application for a new class 1 drug "Yiluok Tablets" .
In October 2019, Qilu initiated a phase III clinical study (CTR20191231) comparing WX-0593 tablets and crizotinib in the treatment of ALK-positive non-small cell lung cancer.
-
Local rules for the management of traditional Chinese medicine formula granules are implemented!
Time of Update: 2021-07-30
Fully liberalized access Establish the only procurement channel According to the "Announcement", Hainan Province requires in the "Implementation Rules" that enterprises that produce granules of traditional Chinese medicine should obtain the "Drug Production License" and have the scope of production of Chinese medicine decoction pieces and granules .
-
The adjustment of the national medical insurance drug catalogue starts in 2021
Time of Update: 2021-07-30
The "Announcement of the Medical Insurance Catalog Adjustment Plan: Increased pharmaceutical company symposiums and no longer publishes the original price of the products" released by the WeChat public account "Health and Knowledge Bureau" stated that the "plan" will be added from June to July this year and will be adopted through seminars and other forms Fully soliciting opinions from relevant parties reflects the positive attitude of the National Medical Insurance Administration to open its doors and accept opinions .
-
"The Lancet": Infecting New Crown or Affecting Intelligence
Time of Update: 2021-07-30
Liu Xia Between January and December last year, researchers from Imperial College, King’s College, University of Cambridge, University of Southampton and University of Chicago conducted intelligence tests on 81,337 people-including about 13,000 people infected with the new crown virus.
-
Second-line indications for liver cancer: What is the efficacy of domestic PD-1 when drug O is withdrawn and drug K is approved?
Time of Update: 2021-07-30
However, in the confirmatory clinical trial CheckMate-459, according to the pre-specified analysis, O drug and sorafenib first-line treatment of liver cancer, although the ORR data consistent with the previous accelerated approval was achieved, the primary endpoint of OS did not reach the statistics.
-
Tanabe Mitsubishi's "Titagliptin Tablets" for the treatment of type 2 diabetes will soon be approved
Time of Update: 2021-07-30
At present, only the original research Tanabe Mitsubishi has applied in China; Kelun Pharmaceutical has submitted an application for the marketing of 3 types of generic drugs, but it has finally been approved for clinical use and has not yet been submitted again .
-
Experts explain in detail: Is the new crown vaccine boosted?
Time of Update: 2021-07-30
Jin Dongyan believes that foreign countries have already implemented the new crown vaccine booster injection for some people, and this issue should also be considered in China .
-
The number of local cases has increased to 153!
Time of Update: 2021-07-30
In this battle, Nanjing faces four major tests Chinanews client, Beijing, July 28 (Reporter Zhang Ni) According to the latest data from the National Health Commission, on the 27th, there were 55 new local cases of new coronary pneumonia in 31 provinces, including 48 in Jiangsu, 3 in Sichuan, and Liaoning.
-
WHO: Delta mutant virus has spread to 132 countries and regions
Time of Update: 2021-07-30
According to data from the World Health Organization, as of July 28, there were more than 195 million confirmed cases of COVID-19 worldwide and more than 4.
-
Gao Fu: Vaccines can provide basic immunity and significantly reduce the burden of disease
Time of Update: 2021-07-30
China News Service, Beijing, July 27 (Hao Lingyu) Regarding whether the new crown pneumonia vaccine is effective for mutant virus strains, Gao Fu, director of the China Centers for Disease Control and Prevention, stated in Beijing on the 27th that the vaccine can provide basic immunity and be effective in reducing the burden of disease.
-
Hengrui Medicine Fondaparinux Sodium Injection Passed Consistency Evaluation
Time of Update: 2021-07-30
On July 28, Hengrui Medicine issued an announcement stating that it had recently received the "Drug Supplementary Application Approval Notice" for Fondaparinux Sodium Injection approved and issued by the State Food and Drug Administration, and the drug passed the consistency evaluation of generic drugs .
-
The "dual channel" of centralized procurement and national talks promotes changes in the pharmaceutical industry
Time of Update: 2021-07-30
"Make space, adjust structure, and ensure convergence", policy and supervision are linked together In recent years, the reform of medical insurance has been continuously explored and improved to promote the refined management of hospitals , which has a profound impact on the development of the industry .
-
Domestic bevacizumab accelerates its competition for the "tens of billions" market
Time of Update: 2021-07-30
Combined treatment effect "1+1>2 " Statistics from the International Agency for Research on Cancer (IARC) of the World Health Organization show that in 2020, among the new cancers in China, the top ten cases are lung cancer, colorectal cancer, gastric cancer, breast cancer, liver cancer, esophageal cancer, and thyroid cancer.
